272
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Granulomatous lung inflammation is nanoparticle type-dependent

, , , , , , , , , , & show all
Pages 25-39 | Received 31 Oct 2017, Accepted 29 Nov 2017, Published online: 11 Jan 2018

References

  • Morimoto Y, Izumi H, Kuroda E. Significance of persistent inflammation in respiratory disorders induced by nanoparticles. J Immunol Res. 2014;2014:962871. doi:10.1155/2014/962871.
  • Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol. 2005;207(3):221–231. doi:10.1016/j.taap.2005.01.008.
  • Huizar I, Malur A, Midgette YA, Kukoly C, Chen P, Ke PC, et al. Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes. Am J Respir Cell MolBiol. 2011;45(4):858–866. doi:10.1165/rcmb.2010-0401OC.
  • Ho CC, Chang H, Tsai HT, Tsai MH, Yang CS, Ling YC, et al. Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung. Nanotoxicology. 2013;7(1):105–115. doi:10.3109/17435390.2011.635814.
  • Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, Aldrich TK, et al. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007;131(5):1414–1423. doi:10.1378/chest.06-2114.
  • Broos CE, van Nimwegen M, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Granuloma formation in pulmonary sarcoidosis. Front Immunol. 2013;4:437. doi:10.3389/fimmu.2013.00437.
  • Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155–1167. doi:10.1016/S0140-6736(13)60680-7.
  • Dugas M, Wallaert B, Tonnel AB, Voisin C. From subclinical alveolitis to granulomatosis. Sequential evaluation of pulmonary involvement in extrathoracic sarcoidosis. Chest. 1989;96(4):931–933. doi:10.1378/chest.96.4.931.
  • Hunninghake GW, Fulmer JD, Young RC, Jr, Gadek JE, Crystal RG. Localization of the immune response in sarcoidosis. Am Rev Respir Dis. 1979;120(1):49–57.
  • Guyot N, Wartelle J, Malleret L, Todorov AA, Devouassoux G, Pacheco Y, et al. Unopposed Cathepsin G, Neutrophil Elastase, and Proteinase 3 Cause Severe Lung Damage and Emphysema. Am J Pathol. 2014;184(8):2197–2210. doi:10.1016/j.ajpath.2014.04.015.
  • Hirche TO, Atkinson JJ, Bahr S, Belaaouaj A. Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites. AmJRespirCell MolBiol. 2004;30(4):576–584. doi:10.1165/rcmb.2003-0253OC.
  • Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. AmJPathol. 2003;163(6):2329–2335. doi:10.1016/S0002-9440(10)63589-4.
  • Benabid R, Wartelle J, Malleret L, Guyot N, Gangloff S, Lebargy F, et al. Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia. J Biol Chem. 2012;287(42):34883–34894. doi:10.1074/jbc.M112.361352.
  • Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7): RESEARCH0034. doi:10.1186/gb-2002-3-7-research0034.
  • Kamada S, Kubota T, Hirata Y, Taguchi M, Eguchi S, Marumo F, et al. Direct effect of endothelin-1 on the granuloma cells of the porcine ovary. J Endocrinol. 1992;134(1):59–66. doi:10.1677/joe.0.1340059.
  • Letizia C, Danese A, Reale MG, Caliumi C, Delfini E, Subioli S, et al. Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission. Panminerva Med. 2001;43(4):257–261.
  • Massai L, Volpi N, Carbotti P, Fruschelli M, Mencarelli M, Pecorelli A, et al. Endothelin-1 and endothelin-converting enzyme-1 in human granulomatous pathology of eyelid: an immunohistochemical and in situ hybridization study in chalazia. Histol Histopathol. 2007;22(12):1343–1354.
  • Korniejewska A, McKnight AJ, Johnson Z, Watson ML, Ward SG. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology. 2011;132(4):503–515. doi:10.1111/j.1365-2567.2010.03384.x.
  • Kishi J, Nishioka Y, Kuwahara T, Kakiuchi S, Azuma M, Aono Y, et al. Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice. Eur Respir J. 2011;38(2):415–424. doi:10.1183/09031936.00070610.
  • Kamphuis LS, van Zelm MC, Lam KH, Rimmelzwaan GF, Baarsma GS, Dik WA, et al. Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis? Am J Respir Crit Care Med. 2013;187(4):406–416. doi:10.1164/rccm.201206-1024OC.
  • Kasai T, Gotoh K, Nishizawa T, Sasaki T, Katagiri T, Umeda Y, et al. Development of a new multi-walled carbon nanotube (MWCNT) aerosol generation and exposure system and confirmation of suitability for conducting a single-exposure inhalation study of MWCNT in rats. Nanotoxicology. 2014;8(2):169–178. doi:10.3109/17435390.2013.766277.
  • Piotrowski WJ, Nawrocka-Kunecka A, Antczak A, Marczak J, Biernacki R, Kordek P, et al. Metalloproteinases MMP-9, MMP-2 and their tissue inhibitors TIMP-1, TIMP-2 in peripheral transbronchial lung biopsies of patients with sarcoidosis. Pol Arch Med Wewn. 2009;119(10):628–635.
  • Dumortier H. When carbon nanotubes encounter the immune system: desirable and undesirable effects. Adv Drug Deliv Rev. 2013;65(15):2120–2126. doi:10.1016/j.addr.2013.09.005.
  • Xiao Y, Forry SP, Gao X, Holbrook RD, Telford WG, Tona A. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake. J Nanobiotechnology. 2010;8:13. doi:10.1186/1477-3155-8-13.
  • Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 2012;9:20. doi:10.1186/1743-8977-9-20.
  • Lapaquette P, Guzzo J, Bretillon L, Bringer MA. Cellular and Molecular Connections between Autophagy and Inflammation. Mediators Inflamm. 2015;2015:398483. doi:10.1155/2015/398483.
  • Chen HC, Sun B, Tran KK, Shen H. Effects of particle size on toll-like receptor 9-mediated cytokine profiles. Biomaterials. 2011;32(6):1731–1737. doi:10.1016/j.biomaterials.2010.10.059.
  • O'Callaghan DS, Savale L, Yaici A, Natali D, Jais X, Parent F, et al. Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother. 2011;12(10):1585–1596. doi:10.1517/14656566.2011.564159.
  • Cordova FC, D'Alonzo G. Sarcoidosis-associated pulmonary hypertension. Curr Opin Pulm Med. 2013;19(5):531–537. doi:10.1097/MCP.0b013e328363f4a3.
  • Reichenberger F, Schauer J, Kellner K, Sack U, Stiehl P, Winkler J. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Lung. 2001;179(3):163–174. doi:10.1007/s004080000058.
  • Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest. 2003;124(3):922–928. doi:10.1016/S0012-3692(15)37649-2.
  • Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J. 2005;25(5):783–788. doi:10.1183/09031936.05.00083404.
  • Huang LH, He JY, Yuan BX, Cao YX. Lipid soluble smoke particles upregulate endothelin receptors in rat basilar artery. Toxicol Lett. 2010;197(3):243–255. doi:10.1016/j.toxlet.2010.06.006.
  • Weldy CS, Wilkerson HW, Larson TV, Stewart JA, Kavanagh TJ. DIESEL particulate exposed macrophages alter endothelial cell expression of eNOS, iNOS, MCP1, and glutathione synthesis genes. Toxicol In Vitro. 2011;25(8):2064–2073. doi:10.1016/j.tiv.2011.08.008.
  • Godefroy E, Gallois A, Idoyaga J, Merad M, Tung N, Monu N, et al. Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses. Cell Rep. 2014;9(5):1856–1870. doi:10.1016/j.celrep.2014.10.067.
  • Hanania R, Sun HS, Xu K, Pustylnik S, Jeganathan S, Harrison RE. Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion. JBiolChem. 2012;287(11):8468–8483. doi:10.1074/jbc.M111.290676.
  • Lund AK, Lucero J, Lucas S, Madden MC, McDonald JD, Seagrave JC, et al. Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler Thromb Vasc Biol. 2009;29(4):511–517. doi:10.1161/ATVBAHA.108.176107.
  • Terada K, Horinouchi T, Fujioka Y, Higashi T, Nepal P, Horiguchi M, et al. Agonist-promoted ubiquitination differentially regulates receptor trafficking of endothelin type A and type B receptors. J Biol Chem. 2014;289(51):35283–35295. doi:10.1074/jbc.M113.544171.
  • Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol. 2016;16(11):661–675. doi:10.1038/nri.2016.100.
  • Xia L, Gu W, Zhang M, Chang YN, Chen K, Bai X, et al. Endocytosed nanoparticles hold endosomes and stimulate binucleated cells formation. Part Fibre Toxicol. 2016;13(1):63. doi:10.1186/s12989-016-0173-1.
  • Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res. 1994;20(6):473–490. doi:10.3109/01902149409031733.
  • Shang X, Qiu B, Frait KA, Hu JS, Sonstein J, Curtis JL, et al. Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol. 2000;157(6):2055–2063. doi:10.1016/S0002-9440(10)64844-4.
  • Ho CC, Luo YH, Chuang TH, Yang CS, Ling YC, Lin P. Quantum dots induced monocyte chemotactic protein-1 expression via MyD88-dependent Toll-like receptor signaling pathways in macrophages. Toxicology. 2013;308:1–9. doi:10.1016/j.tox.2013.03.003.
  • Agrawal S, Gupta S. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J Clin Immunol. 2011;31(1):89–98. doi:10.1007/s10875-010-9456-8.
  • Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96–105. doi:10.1111/j.0105-2896.2004.00214.x.
  • Hu Y, Yibrehu B, Zabini D, Kuebler WM. Animal models of sarcoidosis. Cell Tissue Res. 2017;367(3):651–661. doi:10.1007/s00441-016-2526-3.
  • Idali F, Wahlstrom J, Muller-Suur C, Eklund A, Grunewald J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol. 2008;152(1):127–137. doi:10.1111/j.1365-2249.2008.03609.x.
  • Veltkamp M, Van Moorsel CH, Rijkers GT, Ruven HJ, Van Den Bosch JM, Grutters JC. Toll-like receptor (TLR)-9 genetics and function in sarcoidosis. Clin Exp Immunol. 2010;162(1):68–74. doi:10.1111/j.1365-2249.2010.04205.x.
  • Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA, et al. Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol. 2013;173(3):512–522. doi:10.1111/cei.12138.
  • Perlman SE, Friedman S, Galea S, Nair HP, Eros-Sarnyai M, Stellman SD, et al. Short-term and medium-term health effects of 9/11. Lancet. 2011;378(9794):925–934. doi:10.1016/S0140-6736(11)60967-7.
  • Grutters JC, Sato H, Pantelidis P, Ruven HJ, McGrath DS, Wells AU, et al. Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20(1):20–27.
  • Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011;66(2):144–150. doi:10.1136/thx.2010.140319.
  • Ten Berge B, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN, et al. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology. 2012;51(1):37–46. doi:10.1093/rheumatology/ker316.
  • Bingisser R, Speich R, Zollinger A, Russi E, Frei K. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis. Respiration. 2000;67(3):280–286. doi:10.1159/000029511.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.